EUVIMEDEUVIMED entdecken
Open Access

Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant

Jason W Greenberg, Kevin Kulshrestha, Amalia Guzman-Gomez, Katrina Fields, David G Lehenbauer, David S Winlaw, Tanya Perry, Chet Villa, Angela Lorts, Farhan Zafar, David L S Morales

The Journal of Thoracic and Cardiovascular Surgery · 2024

DOI: 10.1016/j.jtcvs.2023.06.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2024. Verfasst von Jason W Greenberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: j…. Hauptthemen laut MEDLINE: Heart-Assist Devices, Heart Transplantation, Kidney Diseases, Heart Failure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Ventricular assist devices (VADs) are associated with a mortality benefit in children. Database-driven analyses have associated VADs with reduction of modifiable risk factors (MRFs), but validation with institutional data is required. The authors studied MRF reduction on VAD and the influence of persistent MRFs on survival after heart transplant. METHODS: All patients at the authors' institution requiring a VAD at transplant (2011-2022) were retrospectively identified. MRFs included renal dysfunction (estimated glomerular filtration rate .1). CONCLUSIONS: VADs are associated with MRF reduction in children, yet those with persistent MRFs at transplant experience a high burden of mortality. Transplanting VAD patients with ≥3 MRFs may not be prudent. Time should be given on VAD support to achieve aggressive pre-transplant optimization of MRFs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesHeart TransplantationKidney DiseasesHeart FailureChildHumansRetrospective StudiesRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

congenital heart diseaseheart transplantationmodifiable risk factorspediatric heart transplantationventricular assist device

Autor:innen und Institutionen

  • Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio. Electronic address: jasongreenbergmd@gmail.com.
  • Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Greenberg, J. W., Kulshrestha, K., Guzman-Gomez, A., Fields, K., Lehenbauer, D. G., Winlaw, D. S., Perry, T., Villa, C., Lorts, A., Zafar, F., & Morales, D. L. S. (2024). Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2023.06.015

Vancouver

Greenberg JW, Kulshrestha K, Guzman-Gomez A, Fields K, Lehenbauer DG, Winlaw DS, et al. Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant. The Journal of Thoracic and Cardiovascular Surgery. 2024. doi:10.1016/j.jtcvs.2023.06.015

BibTeX
@article{Greenberg2024,
  author = {Greenberg, Jason W and Kulshrestha, Kevin and Guzman-Gomez, Amalia and Fields, Katrina and Lehenbauer, David G and Winlaw, David S and Perry, Tanya and Villa, Chet and Lorts, Angela and Zafar, Farhan and Morales, David L S},
  title = {Modifiable risk factor reduction for pediatric ventricular assist devices and the influence of persistent modifiable risk factors at transplant},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2024},
  doi = {10.1016/j.jtcvs.2023.06.015}
}
Kostenlos starten →